Helius Medical Technologies Inc

NASDAQ:HSDTUnited States

NASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)

Helius Medical Technologies, Inc. is a neurotech company in the medical device field. It is focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms enhancing the lives of people dealing with neurologic diseases. It develops, licenses, or acquires non-implantable technologies targeted at reducing symptoms of neurological disease or trauma. Its product Portable Neuromodulation Stimulator (PoNS) is a non-implantable medical device, inclusive of a controller and mouthpiece, which delivers mild electrical stimulation to the surface of the tongue to provide treatment of gait deficit and chronic balance deficit. PoNS Therapy is integral to the overall PoNS solution and is the physical therapy applied by patients during use of the PoNS neuromodulation stimulator. PoNS is used as an adjunct to a supervised therapeutic exercise program in patients 22 years of age and over by prescription only.

Contact Information

Headquarters

642 Newtown Yardley RoadNEWTOWN, PA, United States 18940

Phone

215-944-6100

Fax

302-655-5049

Executives

Independent Chairman of the Board

Blane Walter

President, Chief Executive Officer, Director

Dane Andreeff

Chief Financial Officer, Treasurer, Company Secretary, Director

Jeffrey Mathiesen

Chief Medical Officer

Antonella Favit-Van Pelt

Independent Director

Paul Buckman